1582 studies found for:    "Squamous cell carcinoma"
Show Display Options
Rank Status Study
21 Not yet recruiting Photodynamic Therapy for Treatment of Cutaneous Squamous Cell Carcinoma in Situ
Condition: Squamous Cell Carcinoma
Interventions: Drug: Levulan Kerastick;   Device: blue light source;   Other: participant satisfaction survey
22 Terminated
Has Results
Afatinib After Chemoradiation and Surgery in Treating Patients With Stage III-IV Squamous Cell Carcinoma of the Head and Neck at High-Risk of Recurrence
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: afatinib;   Other: placebo
23 Completed Study of TARCEVA (Erlotinib) as Adjuvant Treatment for Locally Advanced Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Erlotinib;   Drug: Erlotinib plus sulindac;   Drug: Placebo
24 Completed Molecular Effects of Short-Term Celecoxib Treatment on Head and Neck Squamous Cell Carcinoma
Condition: SQUAMOUS CELL CARCINOMA
Intervention: Drug: celecoxib
25 Recruiting Study of Concurrent Chemoradiotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma
Condition: Esophageal Squamous Cell Carcinoma
Interventions: Drug: Docetaxel;   Drug: Nedaplatin;   Radiation: chest radiation
26 Not yet recruiting Quantitative Optical Sensor Findings in Head & Neck Squamous Cell Carcinoma
Condition: Squamous Cell Carcinoma
Intervention: Device: No intervention, this is an observational study
27 Active, not recruiting Ph I Vorinostat in the Treatment of Advanced Staged Oropharyngeal Squamous Cell Carcinoma
Conditions: Stage III Squamous Cell Carcinoma of the Oropharynx;   Stage IV Squamous Cell Carcinoma of the Oropharynx
Interventions: Drug: vorinostat;   Drug: cisplatin;   Radiation: radiation therapy;   Procedure: Correlative Studies
28 Completed Study Evaluating Temsirolimus in Advanced Stage Squamous Cell Carcinoma of the Head & Neck
Condition: Squamous Cell Carcinoma
Intervention: Drug: Temsirolimus
29 Terminated Selinexor Treatment of Advanced Relapsed/Refractory Squamous Cell Carcinomas
Condition: Squamous Cell Carcinoma
Intervention: Drug: Selinexor (KPT-330)
30 Terminated Azacitidine and Cisplatin for Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma
Interventions: Drug: Azacitidine;   Drug: Cisplatin
31 Completed Nimotuzumab in Combination With TPF(Cisplatin ,Fluorouracil and Docetaxel) for Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: Chemotherapy;   Drug: Nimotuzumab and Chemotherapy
32 Recruiting Trial Using Gilotrif for Advanced Penile Squamous Cell Carcinoma
Condition: Penile Squamous Cell Carcinoma (PSCC)
Intervention: Drug: Gilotrif
33 Not yet recruiting Study of the Efficacy of Single Agent BGJ398 in FGFR1-3 Translocated, Mutated, or Amplified Squamous Cell Carcinoma of the Head and Neck
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Drug: BGJ398
34 Active, not recruiting Metastases of Cutaneous Squamous Cell Carcinoma in Organ Transplant Recipients. The "SCOPE-ITSCC Metastases Study"
Condition: Squamous Cell Carcinoma
Intervention: Other: SCC metastasis
35 Completed Proximal Molecular Effects of Concurrent Chemoradiotherapy on Head and Neck Squamous Cell Carcinoma
Condition: Head and Neck Squamous Cell Carcinoma
Intervention: Biological: the arachidonic acid and EGFR signaling pathways and their interaction in HNSCC tumorigenesis,
36 Completed New Strategies Against Cutaneous Squamous Cell Carcinoma
Condition: Cutaneous Squamous Cell Carcinoma
Intervention: Radiation: Samples with 2 treatments
37 Not yet recruiting A Study to Investigate Biomarker Effects of Pre-Surgical Treatment With DNA Damage Repair (DDR) Agents in Patients With Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: AZD6738;   Drug: Olaparib
38 Completed Study Comparing Two Treatments in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck
Condition: Squamous Cell Carcinoma of the Head and Neck
Interventions: Drug: Cabazitaxel;   Drug: Methotrexate
39 Terminated Docetaxel and S-1 in Head and Neck Squamous Cell Carcinoma (HNSCC)
Condition: Head and Neck Squamous Cell Carcinoma
Interventions: Drug: docetaxel+CDDP;   Drug: docetaxel+S-1
40 Completed Microarray Analysis of microRNA Expression Profiles in Cutaneous Squamous Cell Carcinoma
Condition: Cutaneous Squamous Cell Carcinoma
Intervention:

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.